New Drugs Target 'Zombie' Cells to Combat Cancer and Aging
Similar Articles
Review Maps Paths to Target Senescent Cells for Anti-Aging Interventions
Mayo Clinic Researchers Develop New Method to Tag Aging 'Zombie' Cells
Scientists Reverse Aging in Blood Stem Cells by Repairing Lysosomes
Topical Drug Reduces Aging Signs and Speeds Wound Healing in Mice
Engineered Nanoparticles Show Promise in Restoring Brain Waste Removal in Alzheimer's Mouse Model
Researchers have identified compounds that selectively kill senescent cells, often called 'zombie-like' cells. These cells accumulate with age and after chemotherapy, contribute to cancer spread. The drugs work by removing a protective protein that shields these cells from a form of cell death. Early mouse studies show reduced tumor size. The approach may offer new ways to treat cancer aging-related conditions.
Facts First
- New compounds target senescent cells — cells that no longer divide אך remain active.
- Senescent cells are linked to cancer spread — they release molecules that damage tissue.
- Drugs remove protective protein GPX4 — making the cells vulnerable to a specific death process.
- Early tests in mice reduced tumors — killing senescent cells showed promise.
- Research involved UK, Swiss, German teams — study published in Nature Cell Biology.
What Happened
Researchers at the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have discovered that removing a protective protein can force senescent cells into self-destruction. Senescent cells, sometimes called 'zombie-like' cells, survive by producing large amounts of this protein. Cancer involves uncontrolled cell division, tumors also contain these non-dividing, active cells. Chemotherapy often increases their number. The research team tested over 10,000 different compounds on both senescent and healthy cells to find potential treatments.
Why this Matters to You
Senescent cells release molecules that can damage nearby tissue, encourage cancer spread, and trigger harmful immune system activity. They are also linked to aging-related conditions such as fibrosis. The new approach targets these problematic cells directly. If developed into treatments, it could help clear these cells from patients after chemotherapy and potentially slow aging processes.
What's Next
The researchers, their collaborators will continue to refine the compounds and explore their effectiveness in other disease models. The lead author noted the need for further testing before human trials. The study provides a new target for drug development against senescent cells. Future work will investigate whether removing these cells can improve outcomes for various age-related diseases.